LS

Lithesh Sunkari

Director Director DIN 06793695
DIN 06793695 First appointment Feb 2014 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Lithesh Sunkari

Data last updated:

Lithesh Sunkari was a Director at Sungurus Pharma India Private Limited (2014–2015) and Director at Dr Lithesh Pharmaceuticals Private Limited (from 2015). The companies operate in Chemicals.

DIN 06793695
Primary Designation Director
Industry Chemicals
First Appointment 12 Feb 2014
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Feb 20142014Strike Off
Director28 May 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dr Lithesh Pharmaceuticals Private Limited
Sungurus Pharma India Private Limited
Premium access

Shareholding and investment profile for Lithesh Sunkari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lithesh Sunkari

Lithesh Sunkari was first appointed on 12 Feb 2014 as Director at Sungurus Pharma India Private Limited. The most recent appointment on record is 28 May 2015 at Dr Lithesh Pharmaceuticals Private Limited.

Lithesh Sunkari held 2 earlier board appointments: Sungurus Pharma India Private Limited (Director, 12 Feb 2014 to 21 Jan 2015); Dr Lithesh Pharmaceuticals Private Limited (Director, from 28 May 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available